RU-486 Suspension and Review Act of 2003
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
RU-486 Suspension and Review Act of 2003 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been suspended.
Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the contingent reinstatement of such drug if the report determines the approval to have been in accordance with the Federal Food, Drug, and Cosmetic Act.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 3453: RU-486 Suspension and Review Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-3453/
"H.R. 3453: RU-486 Suspension and Review Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-3453/.
H.R. 3453, 108th Cong. (2026), https://openamerica.io/bill/108-HR-3453/.
[H.R. 3453: RU-486 Suspension and Review Act of 2003](https://openamerica.io/bill/108-HR-3453/)